SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-067151
Filing Date
2023-08-14
Accepted
2023-08-14 16:40:53
Documents
90
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_avalonglobocare.htm   iXBRL 10-Q 1562912
2 CERTIFICATION f10q0623ex31-1_avalonglobo.htm EX-31.1 9061
3 CERTIFICATION f10q0623ex31-2_avalonglobo.htm EX-31.2 9278
4 CERTIFICATION f10q0623ex32-1_avalonglobo.htm EX-32.1 3308
5 CERTIFICATION f10q0623ex32-2_avalonglobo.htm EX-32.2 3423
  Complete submission text file 0001213900-23-067151.txt   8192324

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE avco-20230630.xsd EX-101.SCH 103688
7 XBRL CALCULATION FILE avco-20230630_cal.xml EX-101.CAL 51925
8 XBRL DEFINITION FILE avco-20230630_def.xml EX-101.DEF 437858
9 XBRL LABEL FILE avco-20230630_lab.xml EX-101.LAB 825622
10 XBRL PRESENTATION FILE avco-20230630_pre.xml EX-101.PRE 454941
84 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_avalonglobocare_htm.xml XML 911371
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38728 | Film No.: 231171325
SIC: 2836 Biological Products, (No Diagnostic Substances)